drugset / Trial / NCT00132171
Helicobacter Pylori Eradication With a New Sequential Treatment
RandomizedParallel-groupOpen-labelTreatment
Summary
Eradication rates of Helicobacter pylori (H. pylori) with standard triple therapy are disappointing, and studies from several countries confirm this poor performance. The study aimed to assess the eradication rate of a new sequential treatment regimen compared with conventional triple therapy for the eradication of H. pylori infection.
Timeline
- Start
- 2001-01
- Primary completion
- —
- Completion
- 2001-12
Outcome
Met primary endpoint
paper Higher eradication rates were found with the sequential regimen compared to the standard regimen (intention-to-treat: 92% vs. 74%, P < 0.0001; PMID 12641522 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | 1 g | — |
| Subject | Clarithromycin | Small molecule | 500 mg | — |
| Subject | Rabeprazole | Small molecule | 20 mg | — |
| Subject | tinidazole | Small molecule | 500 mg | — |